edoc

Items where Author is "Muri, L."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2023 | 2022 | 2021 | 2017
Number of items: 4.

2023

Ispasanie, E. and Muri, L. and Schmid, M. and Schubart, A. and Thorburn, C. and Zamurovic, N. and Holbro, T. and Kammüller, M. and Pluschke, G.. (2023) In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway. Front Immunol, 14. p. 1180833.

2022

Muri, L. and Schubart, A. and Thorburn, C. and Zamurovic, N. and Holbro, T. and Kammüller, M. and Pluschke, G. and Ispasanie, E.. (2022) Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against Haemophilus influenzae type b. Front Immunol, 13. p. 1020580.

2021

Ispasanie, E. and Muri, L. and Schubart, A. and Thorburn, C. and Zamurovic, N. and Holbro, T. and Kammüller, M. and Pluschke, G.. (2021) Alternative complement pathway inhibition does not abrogate meningococcal killing by serum of vaccinated individuals. Front Immunol, 12. p. 747594.

2017

Erb, S. and Letang, E. and Glass, T. R. and Natamatungiro, A. and Mnzava, D. and Mapesi, H. and Haschke, M. and Duthaler, U. and Berger, B. and Muri, L. and Bader, J. and Marzolini, C. and Elzi, L. and Klimkait, T. and Langewitz, W. and Battegay, M. and Kilombero Ulanga Antiretroviral Cohort study group, . (2017) Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems. HIV medicine, 18 (9). pp. 623-634.

This list was generated on Thu Apr 18 13:44:38 2024 CEST.